Sales of reagents and devices related to physics and chemistry

research and development such as cosmetic, quasi drug, and health food

Regulatory consultation and clinical development service for Cell and Gene Therapy (CAGT), innovative pharmaceutical product and medical device

Overview

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry dedicated to creating intelligent connections that deliver unique and actionable insights. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.

Contract Packaging ,R&D

Overview

KANAE was founded in 1956 as a business that processes and sells flexible packaging materials. Since then, we have expanded our business throughout the world, and nowadays widely offer optimal packaging solutions to almost 700 valued customers in the pharmaceutical, medical, cosmetics and food industries, by utilizing rich experience, know-how, and R&D capabilities.
In order to expand and enhance our business foundation, we established a creative/development type plant and R&D Lab. in Port Island.

Research, development, and production solutions for organic chemicals

Overview

KNC Laboratories provides R&D and manufacturing services promptly and flexibly in any phase of your activity, from early research to commercial production.
KNC Laboratories has been serving a variety of industries including pharmaceutical, electronic- chemical, agrochemical, energy, environment.
With expertise in organic chemistry and biochemistry, KNC Laboratories offers services such as OEM, R&D manufacturing, FTE to meet the client's requirements in any phase of the business.

R&D and production of functional cosmetics

Drug discovery research on autoimmune disease and cancer, etc.

Overview

Meiji Seika Pharma (“Meiji”), since its predecessor launched penicillin in 1946, has been providing high-quality pharmaceutical products in Japan and overseas. As a “Speciality & Generic Pharmaceutical Company”, Meiji focuses its pharmaceutical business on infectious disease, central nervous system disorders, and generic drugs as well. It strives to respond to medical needs and contributes to the well-being of people worldwide.

Logistics & management of medical supplies (Pharmaceuticals, Medical Devices, Investigational new drug, Cosmetics etc)

Overview

●Warehousing (Offering storage, distribution service around the world.)
●International transportation (With numbers of overseas subsidiaries & agencies, we provide you with high quality international transportation service that is combined closely with inland logistics.)
●Port and harbor operation (As agency of mega carrier, we are offering vessel loading / unloading, marshalling / storage services at major Japanese ports.)
●Real estate development & leasing (Developing / leasing office buildings & apartment houses at Kobe Harborland area including management of “umie” retail facility.)

R&D of medicine

Overview

The Boehringer Ingelheim Group has been operating globally, focusing on researching, developing, manufacturing and marketing novel medications as a family-owned, independent company consistently oriented towards long-term sustainable organic growth.
With our vision “Value through Innovation”, we have committed ourselves to the goal of serving humankind through research into development of new drugs and therapies. Some 50,000 employees are active in the world.
Boehringer Ingelheim has been operating in Japan and providing innovative prescription medicine in the area of diabetic, cardiometabolic, respiratory, oncology and central nervous system diseases.
As one of Boehringer Ingelheim Group’s research centers, Kobe Pharmaceutical Research Institute supports global research and development, conducting early drug formulation and specific pharmacokinetic investigations.